Marlin Global (MLN) H2 2025 earnings summary

Executive summary

• Recorded a net profit of $0.3m for FY25, a significant decline from $37.2m in FY24, amid global market volatility and sector-specific headwinds, especially in healthcare.

• Total shareholder return was 2.8% and adjusted NAV return was 0.2%, both well below the 14.9% benchmark index return for the year ended 30 June 2025.

• Portfolio remains focused on quality, growth-oriented international companies, with confidence in long-term prospects despite short-term underperformance.

Financial highlights

• Net profit after tax: $0.3m (FY24: $37.2m).

• Gross performance return: 2.7% vs. benchmark index return of 14.9%.

• Total shareholder return: 2.8%; adjusted NAV return: 0.2%.

• Dividends paid: 8.01 cents per share (FY24: 7.59 cps).

• NAV per share: $0.95; share price: $0.91 as at 30 June 2025.

• OPEX ratio: 1.5% (down from 2.2% in FY24).

Outlook and guidance

• Expectation of continued global economic and geopolitical uncertainty, with further tariff disruptions likely in 2H 2025.

• Portfolio companies expected to deliver solid earnings; optimism for long-term growth and returns.

• Valuations elevated; investors advised to remain nimble amid rapid technological and macroeconomic changes.